Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2025 Apr 9;41(1):111.
doi: 10.1007/s00383-025-06006-w.

Comparing the efficacy of video assisted thoracoscopic surgery (VATS) vs intrapleural fibrinolytic therapy in children with pleural empyema

Affiliations
Randomized Controlled Trial

Comparing the efficacy of video assisted thoracoscopic surgery (VATS) vs intrapleural fibrinolytic therapy in children with pleural empyema

Mohammad Omid et al. Pediatr Surg Int. .

Abstract

Purpose: To compare the effects of video-assisted thoracoscopic surgery (VATS) and fibrinolytic injection into the pleural space in children with empyema.

Methods: This randomized clinical trial included 51 children with empyema, who were divided into two groups. In the first group (25 patients), VATS was performed, while in the second group (26 patients), 0.1 mg/kg of Reteplase was injected into the pleural space for 3 days. The length of hospitalization, pediatric intensive care unit (PICU) stay, duration of fever and dyspnea, duration of antibiotic administration, duration of chest tube presence, and the need for reoperation were compared between the groups.

Results: In the Reteplase injection and VATS groups, the mean duration of hospitalization was 21.1 ± 7.5 and 12.3 ± 6 days (P < 0.001), respectively, and the length of PICU stay was 7.8 ± 3.8 and 1.9 ± 2.3 days (P < 0.001), respectively. The duration of antibiotic administration was significantly longer in the Reteplase group. The chest tubes were present for a longer duration in the Reteplase group, and the duration of fever was also significantly longer.

Conclusion: VATS surgery in children with empyema is associated with more favorable clinical outcomes compared to fibrinolytic therapy with Reteplase.

Keywords: Fibrinolytic agents; Pleural empyema; Reteplase; Video-assisted thoracic surgery.

PubMed Disclaimer

Conflict of interest statement

Declarations. Conflict of interest: The authors declare no competing interests. Ethical approval: The protocol of this study was approved by the Research Ethics Committee of the Isfahan University of Medical Sciences (IR.MUI.MED.REC.1398.576).

References

    1. Altmann ES, Crossingham I, Wilson S, Davies HR (2019) Intra-pleural fibrinolytic therapy versus placebo, or a different fibrinolytic agent, in the treatment of adult parapneumonic effusions and empyema. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD002312.pub4 - DOI - PubMed - PMC
    1. Elemraid MA, Thomas MF, Blain AP et al (2015) Risk factors for the development of pleural empyema in children. Pediatr Pulmonol 50:721–726. https://doi.org/10.1002/ppul.23041 - DOI - PubMed
    1. Komissarov AA, Rahman N, Lee YCG et al (2018) Fibrin turnover and pleural organization: bench to bedside. Am J Physiol Lung Cell Mol Physiol 314:L757–L768. https://doi.org/10.1152/ajplung.00501.2017 - DOI - PubMed - PMC
    1. Mierzejewski M, Korczynski P, Krenke R, Janssen JP (2019) Chemical pleurodesis - a review of mechanisms involved in pleural space obliteration. Respir Res 20:247. https://doi.org/10.1186/s12931-019-1204-x - DOI - PubMed - PMC
    1. Elsayed HH, Mostafa A, Fathy E et al (2018) Thoracoscopic management of early stages of empyema: is this the golden standard? J Vis Surg 4:114. https://doi.org/10.21037/jovs.2018.05.18 - DOI - PubMed - PMC

Publication types

MeSH terms

Substances

LinkOut - more resources